Banque Transatlantique’s Immunocore IMCR Stock Holding History

Banque Transatlantique’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$322K	Buy	+10,150	New	+$300K	0.01%	264

Other funds holding IMCR

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Banque Transatlantique's IMCR Position: Q2 2026 in Review

Banque Transatlantique opened a new position in Immunocore (IMCR) in Q2 2026: 10,150 shares worth $322K. The stake represents 0.01% of the portfolio and ranks #264 among its holdings.

21 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Banque Transatlantique held 10,150 shares of Immunocore worth $322K as of Q2 2026.
Immunocore was a new Banque Transatlantique position in Q2 2026.
Immunocore made up 0.01% of Banque Transatlantique's portfolio in Q2 2026, its #264 holding.
21 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.